Geron Announces November Investor Conference Presentation Webcasts
November 07 2017 - 7:30AM
Geron Corporation (Nasdaq:GERN) today announced that John A.
Scarlett, M.D., President and Chief Executive Officer, is scheduled
to present at the following investor conferences:
- Stifel 2017 Healthcare Conference in New York at 4:15 p.m. ET
on Tuesday, November 14, 2017.
- Piper Jaffray 29th Annual Healthcare Conference in New York at
3:30 p.m. ET on Tuesday, November 28, 2017.
A live audio webcast of each presentation will be available
through the Investors section of Geron’s website (www.geron.com)
under Events. Following the live presentations, the webcasts will
be archived and available for replay for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the collaborative development of a first-in-class telomerase
inhibitor, imetelstat, in hematologic myeloid malignancies. For
more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.Investor and Media
Relations650-473-7765investor@geron.commedia@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024